PURPOSE: The natural history of the multiple metabolic syndrome (MMS) and its predictors has rarely been addressed in population samples. This study evaluated the predictive role of fasting serum insulin, body mass index (BMI), and waist-to-hip ratio (WHR) on the development of incident MMS components (diabetes, hypertension, and dyslipidemias) over the course of three years. METHODS: The study population comprised the cohort of middle-aged African American and European American men and women of the Atherosclerosis Risk in Communities Study (1987-1992). RESULTS: Among 6113 individuals free of MMS components at baseline, high insulin (> 14 microU/ ml) was independently predictive of the development of one or more MMS components (OR:1.5, 95% CI:1.2-1.8), as was a BMI > or = 30 (OR:1.7, 95% CI:1.4-2.0), and a high WHR (> 0.98) (OR:1.5, 95% CI:1.3-1.8) adjusting statistically for age, gender, and ethnicity/center. These associations were markedly stronger for combinations of MMS components (two or more) than for isolated components. CONCLUSIONS: The findings confirm earlier reports on the predictive role of insulin, BMI, and WHR, and suggest that these antecedent factors may be integral to the development of combinations of disorders, i.e., the particular clustering identified as the MMS.
PURPOSE: The natural history of the multiple metabolic syndrome (MMS) and its predictors has rarely been addressed in population samples. This study evaluated the predictive role of fasting serum insulin, body mass index (BMI), and waist-to-hip ratio (WHR) on the development of incident MMS components (diabetes, hypertension, and dyslipidemias) over the course of three years. METHODS: The study population comprised the cohort of middle-aged African American and European American men and women of the Atherosclerosis Risk in Communities Study (1987-1992). RESULTS: Among 6113 individuals free of MMS components at baseline, high insulin (> 14 microU/ ml) was independently predictive of the development of one or more MMS components (OR:1.5, 95% CI:1.2-1.8), as was a BMI > or = 30 (OR:1.7, 95% CI:1.4-2.0), and a high WHR (> 0.98) (OR:1.5, 95% CI:1.3-1.8) adjusting statistically for age, gender, and ethnicity/center. These associations were markedly stronger for combinations of MMS components (two or more) than for isolated components. CONCLUSIONS: The findings confirm earlier reports on the predictive role of insulin, BMI, and WHR, and suggest that these antecedent factors may be integral to the development of combinations of disorders, i.e., the particular clustering identified as the MMS.
Authors: Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja Journal: Endocr Metab Immune Disord Drug Targets Date: 2010-06 Impact factor: 2.895
Authors: Angelo Scuteri; Christopher H Morrell; Samer S Najjar; Denis Muller; Reubin Andres; Luigi Ferrucci; Edward G Lakatta Journal: J Gerontol A Biol Sci Med Sci Date: 2009-03-06 Impact factor: 6.053
Authors: Martin K Rutter; Lisa M Sullivan; Caroline S Fox; Peter W F Wilson; David M Nathan; Ramachandran S Vasan; Ralph B D'Agostino; James B Meigs Journal: Metab Syndr Relat Disord Date: 2014-07-09 Impact factor: 1.894
Authors: Morgana Mongraw-Chaffin; Meredith C Foster; Cheryl A M Anderson; Gregory L Burke; Nowreen Haq; Rita R Kalyani; Pamela Ouyang; Christopher T Sibley; Russell Tracy; Mark Woodward; Dhananjay Vaidya Journal: J Am Coll Cardiol Date: 2018-05-01 Impact factor: 24.094